MedPath

Comparative Efficacy of Lidocaine Spray Versus Vaginal Dinoprostone in IUD Insertion

Phase 4
Conditions
Contraception
Interventions
Registration Number
NCT04339361
Lead Sponsor
Cairo University
Brief Summary

the aim of this study is to compare the safety and Efficacy of Lidocaine Spray Versus Vaginal dinoprostone in relieving pain during levonorgestrel IUD Insertion in nulliparous women

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
111
Inclusion Criteria
  • nulliparous women requesting levonorgestrel IUD insertion
Exclusion Criteria
  • multiparous women, allergy or contraindication to study drugs or contraindications to LNG-IUD insertion

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
lidocaine spraylidocaine sprayfour puffs (50ml, 10 mg/puff) of lidocaine spray will be applied to the cervical canal and cervix before tenaculum placement plus vaginal placebo will be given 3 hours before IUD insertion
placeboplacebovaginal placebo will be given 3 hours before IUD insertion plus four puffs of saline spray will be applied to the cervical canal and cervix before tenaculum placement
vaginal dinoprostonevaginal dinoprostonevaginal dinoprostone 3 mg will be given 3 hours before IUD insertion plus four puffs of saline spray will be applied to the cervical canal and cervix before tenaculum placement
Primary Outcome Measures
NameTimeMethod
pain during IUD insertion2 minutes

pain during IUD insertion assessed by 10 cm visual analog scale where 0 denotes no pain and 10 denotes the worst pain imaginable

Secondary Outcome Measures
NameTimeMethod
insertion duration5 minutes

duration of LNG-IUD insertion from speculum in to speculum out

© Copyright 2025. All Rights Reserved by MedPath